COGENTIX MEDICAL, INC. (NASDAQ:CGNT) Files An 8-K Results of Operations and Financial ConditionItem 2.02.
Results of Operations and Financial Condition
COGENTIX MEDICAL, INC. (NASDAQ:CGNT) Files An 8-K Results of Operations and Financial Condition
On August 1, 2017, Cogentix Medical, Inc. (the “Company”) issued a press release providing information regarding its results of operations and financial condition for the fiscal quarter ended June 30, 2017.
The Company is furnishing the information contained in this report, including Exhibit 99.1, to Item 2.02 of Form 8-K promulgated by the Securities and Exchange Commission (the “SEC”). This information shall not be deemed to be “filed” with the SEC for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.
| Item 9.01 |
Financial Statements and Exhibits. |
|
Exhibit No. |
Description |
|
99.1 |
Press Release of Cogentix Medical, Inc. dated August 1, 2017 (furnished herewith) |
COGENTIX MEDICAL INC /DE/ ExhibitEX-99.1 2 ex99_1.htm EXHIBIT 99.1 Exhibit 99.1 Cogentix Medical Reports Strong Second Quarter Operating Results with 11% Urology Revenue Growth; Recently Executed Business Development Transactions Expected to Add Approximately 10 Points of Urology Revenue Growth in 2018 Conference Call Today at 4:30 p.m. ET MINNEAPOLIS,…To view the full exhibit click here
About COGENTIX MEDICAL, INC. (NASDAQ:CGNT)
Cogentix Medical, Inc. is a global medical device company. The Company designs, develops, manufactures and markets a line of fiber-optic and video endoscopy products under the PrimeSight brand that are used across various surgical specialties in diagnostic and treatment procedures. The Company also offers the Urgent PC Neuromodulation System (Urgent PC Systems), a device that delivers percutaneous tibial nerve stimulation (PTNS), for the office-based treatment of overactive bladder (OAB). The Company also offers Macroplastique Implants, an injectable urethral bulking agent for the treatment of adult female stress urinary incontinence that is primarily due to intrinsic sphincter deficiency. The PrimeSight flexible endoscopes are used in conjunction with the sterile, single-use microbial barrier known as the EndoSheath Protective Barrier. The PrimeSight endoscopy line also includes rigid endoscopes and portable peripherals, such as the video system and stroboscopy unit.
